US · Healthcare · Healthcare Plans
EPS came in at 4.69 against a street estimate of 4.12 — a beat of 13.8%.
Analysts rate UnitedHealth Group Incorporated a buy (22 buy, 4 hold, 0 sell out of 26) with an average price target of $477.04.
CONFIDENT UnitedHealth reported stronger-than-expected Q3 earnings, raised 2026 EPS guidance, and described improving execution, while medical costs and Medicaid funding remain risks. Q3 FY26 No geographic regional performance breakdown was provided. Analysts focused on Medicaid recovery, Medicare Advantage growth, commercial cost trends, Optum Health margins and 2027 segment outlook. Management emphasized operational improvements but cautioned that medical trends and funding gaps remain significant. 2026-10-13…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.56% |
| Vanguard Capital Management, LLC | 6.61% |
| State Street Corp | 5.08% |
| Capital World Investors | 3.33% |
| FMR Inc | 3.12% |
| Vanguard Portfolio Management, LLC | 2.73% |
| T. Rowe Price Associates, Inc. | 2.58% |
| Geode Capital Management, LLC | 2.42% |
| Document | Date |
|---|---|
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $112.7 billion, compared with $113.2 billion in Q3 2025. • Earnings from operations were $6.6 billion, up fro | 2026-10-13 |
| Reg FD disclosure · Q3 2026 UNITEDHEALTH GROUP INCORPORATED - FORM 8-K SUMMARY OTHER NOTABLE POINTS • Document Type: Form 8-K current report filed September 8, 2026 with the Se | 2026-09-08 |
| Quarterly report · Q2 2026 UNITEDHEALTH GROUP - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net earnings attributable to common shareholders: $5.5 billion (Q2 2026) vs $3.4 billio | 2026-08-10 |
| Results announced · Q3 2026 UNITEDHEALTH GROUP Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 revenues: $112.0 billion (vs. $111.6 billion Q2 2025) • Earnings from operati | 2026-07-16 |
| Shareholder vote results · Q2 2026 UNITEDHEALTH GROUP INCORPORATED – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held June 1, 2026 • 768,066,717 shares of commo | 2026-06-05 |
| Reg FD disclosure · Q2 2026 UNITEDHEALTH GROUP INCORPORATED - DOCUMENT SUMMARY HEADLINE NUMBERS • This is a Form 8-K filing dated May 11, 2026 - a current report disclosing mat | 2026-05-11 |
| Quarterly report · Q1 2026 UNITEDHEALTH GROUP INCORPORATED – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $111,721 million (Q1 2026) vs. $109,575 million (Q1 2025) | 2026-05-05 |
| Proxy statement · Q2 2026 UNITEDHEALTHGROUP INCORPORATED — 2026 PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of Nine Directors — Vote FOR all nominees | 2026-04-21 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $2.32 / share ex-date Sep 14, 2026 · pay Sep 22, 2026 | 2026-09-14 |
| Dividend | $2.32 / share ex-date Jun 15, 2026 · pay Jun 23, 2026 | 2026-06-15 |
| Dividend | $2.21 / share ex-date Mar 9, 2026 · pay Mar 17, 2026 | 2026-03-09 |
| Dividend | $2.21 / share ex-date Dec 8, 2025 · pay Dec 16, 2025 | 2025-12-08 |
| Dividend | $2.21 / share ex-date Sep 15, 2025 · pay Sep 23, 2025 | 2025-09-15 |
| Announcement | Date |
|---|---|
| Full year 2025 results reported; 2026 revenue and earnings outlook issued UnitedHealth Group reported strong 2025 revenues of $447.6 billion (12% growth), but earnings were heavily impacted by a $2.8 billion charge. Adjusted earnings of $16.35 per share exclude on | 2026-01-27 |
| Senior management to reaffirm adjusted 2025 EPS expectations at investor meetings UnitedHealth Group announced that senior management will meet with investors on January 12, 2026, to reaffirm its adjusted 2025 earnings per share (EPS) guidance previously provided on Octob | 2026-01-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for UnitedHealth Group Incorporated — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.